| Healthy weight loss maintenance with exercise, liraglutide, or both combined JR Lundgren, C Janus, SBK Jensen, CR Juhl, LM Olsen, RM Christensen, ... New England Journal of Medicine 384 (18), 1719-1730, 2021 | 294 | 2021 |
| Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial RM Sandsdal, CR Juhl, SBK Jensen, JR Lundgren, C Janus, MB Blond, ... Cardiovascular diabetology 22 (1), 41, 2023 | 65 | 2023 |
| Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised … SBK Jensen, MB Blond, RM Sandsdal, LM Olsen, CR Juhl, JR Lundgren, ... EClinicalMedicine 69, 2024 | 47 | 2024 |
| Benefit-risk assessment of obesity drugs: focus on glucagon-like peptide-1 receptor agonists RM Christensen, CR Juhl, SS Torekov Drug safety 42 (8), 957-971, 2019 | 42 | 2019 |
| Exploratory analysis of eating-and physical activity-related outcomes from a randomized controlled trial for weight loss maintenance with exercise and liraglutide single or … SBK Jensen, C Janus, JR Lundgren, CR Juhl, RM Sandsdal, LM Olsen, ... Nature Communications 13 (1), 4770, 2022 | 27 | 2022 |
| Bone health after exercise alone, GLP-1 receptor agonist treatment, or combination treatment: a secondary analysis of a randomized clinical trial SBK Jensen, V Sørensen, RM Sandsdal, EW Lehmann, JR Lundgren, ... JAMA network open 7 (6), e2416775-e2416775, 2024 | 16 | 2024 |
| Potent incretin‐based therapy for obesity: A systematic review and meta‐analysis of the efficacy of semaglutide and tirzepatide on body weight and waist circumference, and safety ALO Müllertz, RM Sandsdal, SBK Jensen, SS Torekov Obesity Reviews 25 (5), e13717, 2024 | 14 | 2024 |
| Insufficient sleep predicts poor weight loss maintenance after 1 year AF Bogh, SBK Jensen, CR Juhl, C Janus, RM Sandsdal, JR Lundgren, ... Sleep 46 (5), zsac295, 2023 | 5 | 2023 |
| Weight-loss maintenance is accompanied by interconnected alterations in circulating FGF21-adiponectin-leptin and bioactive sphingolipids M Fiorenza, A Checa, RM Sandsdal, SBK Jensen, CR Juhl, MH Noer, ... Cell Reports Medicine 5 (7), 2024 | 3 | 2024 |
| Weight Loss Induces Changes in Vitamin D Status in Women with Obesity but not in Men: A Randomized Clinical Trial R Holt, J Holt, MJ Jorsal, RM Sandsdal, SBK Jensen, S Byberg, CR Juhl, ... The Journal of Clinical Endocrinology & Metabolism, dgae775, 2024 | 1 | 2024 |
| Protocol for a randomised, double-blinded, controlled trial of youth with childhood-onset obesity treated with semaglutide 2.4 mg/week: the RESETTLE trial S Byberg, J Holt, RM Sandsdal, LA Holm, LB Madsen, BJ Christensen, ... BMJ open 14 (11), e082446, 2024 | | 2024 |
| Plasma levels of Liver-Expressed Antimicrobial Peptide 2 (LEAP2) decrease in response to weight loss and treatment with liraglutide and exercise S Byberg, SK Holm, RM Sandsdal, SBK Jensen, CR Juhl, MH Noer, ... Diabetologia 66 (SUPPL 1, 1), S243, 2023 | | 2023 |
| Superior effect of 1-year treatment with GLP-1 receptor agonist and exercise on weight loss maintenance and body composition after a very low-calorie diet: the S-LITE trial SS Torekov, C Janus, J Lundgren, SBK Jensen, CR Juhl, MB Blond, ... DIABETOLOGIA 63 (SUPPL 1), S292-S292, 2020 | | 2020 |
| 139-OR: Superior Effect of 1-Year Treatment with GLP-1 Receptor Agonist and Exercise on Weight Loss Maintenance and Body Composition after a Very Low-Calorie Diet: The S-LITE … C Janus, JR Lundgren, S Jensen, LM Olsen, CR Juhl, MB Blond, ... Diabetes 69 (Supplement_1), 2020 | | 2020 |
| 2028-P: Adding Exercise to Liraglutide Treatment in Weight Loss Maintenance Abolishes the Increase in Heart Rate Seen with Liraglutide Alone: The S-LITE Randomized Trial JR Lundgren, E BLADBJERG, C Janus, L Gliemann, LM Olsen, CR Juhl, ... Diabetes 69 (Supplement_1), 2020 | | 2020 |
Torekov Signe S.University of Copenhagen, Department of Biomedical Sciences在 sund.ku.dk 的电子邮件经过验证
